[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Baker, 1988 - Google Patents

Placebo‐controlled trial of guar in poorly controlled Type II diabetes

Baker, 1988

View PDF @Full View
Document ID
12407449288945023611
Author
Baker P
Publication year
Publication venue
Practical Diabetes International

External Links

Snippet

This study assessed the acceptability and efficacy of guar mini‐tablets in poorly controlled Type II diabetes. Thirty patients were allocated in a random and single‐blind manner to two months of treatment with placebo or guar, 5 gms three times daily. No patient found guar …
Continue reading at wchh.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons

Similar Documents

Publication Publication Date Title
Mako et al. Circulating proinsulin in patients with maturity onset diabetes
Ko et al. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus
Lipsitz et al. Cardiovascular and norepinephrine responses after meal consumption in elderly (older than 75 years) persons with postprandial hypotension and syncope
Vichayanrat et al. Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients
Baker, SG, Joffe, BI, Mendelsohn, D. & Seftel Treatment of homozygous familial hypercholesterolaemia with probucol
Kapoor et al. Defecation syncope: a symptom with multiple etiologies
Howe-Davies et al. Control of maturity-onset diabetes by monitoring fasting blood glucose and body weight
Najemnik et al. Guar and its effects on metabolic control in type II diabetic subjects
Baker Placebo‐controlled trial of guar in poorly controlled Type II diabetes
Luntz et al. Effect of isoniazid on carbohydrate metabolism in controls and diabetics
Groop et al. Treatment failures: a common problem in the management of patients with type II diabetes
AHN et al. Trimethoprim-sulfamethoxazole and hyponatremia
Bloch Jr et al. Cardiovascular Statue of Female
Chouinard et al. Phenothiazine-induced ECG abnormalities: effect of a glucose load
KRUEGER et al. Thrombolysis in heparin-induced thrombocytopenia with thrombosis
Henderson et al. Decreased intraperitoneal insulin requirements during peritonitis on continuous ambulatory peritoneal dialysis.
Zumoff et al. Aggravation of diabetic hyperglycemia by chlordiazepoxide
US4810696A (en) Diethylaminoethyl dextran for decreasing hyperglycemia
FORESTI et al. Amiodarone and antithyroid antibodies
ROGINSKY et al. Double-blind study of phenethyldiguanide in weight control of obese nondiabetic subjects
ALSTON Neurotoxicity of metronidazole
Gransden et al. Verocytotoxin-producing Escherichia coli 0157: H7 and diarrhea
MacGregor et al. Xipamide and cyclopenthiazide in essential hypertension–comparative effects on blood pressure and plasma potassium.
WOLFSTHAL et al. Chlorpropamide and an Antabuse-like reaction
Doar et al. The influence of fenfluramine on oral glucose tolerance tests, plasma sugar and insulin levels in newly diagnosed late-onset diabetic patients